Org chart
David A. Brenner
President & CEO
David A. Brenner
Collapse
Christine Dittmer
Chief Development Officer
Gene Hasegawa
Interim COO
Robin Ryan
Chief Financial Officer
Adrienne Crown
Acting General Counsel & Chief of Compliance
Michael Jackson
SVP, Drug Discovery & Development
Scott LaFee
VP, Communications
Diane M. Klotz
Chief Learning Officer
